Measurement of ex vivo ELISpot interferon-gamma recall responses to Plasmodium falciparum AMA1 and CSP in Ghanaian adults with natural exposure to malaria

• Published in: Malaria journal Vol. 15; no. 1; p. 55
• Main Authors: Ganeshan, Harini, Kusi, Kwadwo A., Anum, Dorothy, Hollingdale, Michael R., Peters, Bjoern, Kim, Yohan, Tetteh, John K. A., Ofori, Michael F., Gyan, Ben A., Koram, Kwadwo A., Huang, Jun, Belmonte, Maria, Banania, Jo Glenna, Dodoo, Daniel, Villasante, Eileen, Sedegah, Martha
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 01.02.2016; BioMed Central
• Subjects: Adult; Care and treatment; Complications and side effects; Computational Biology; Enzyme-Linked Immunospot Assay; Female; Humans; Interferon-gamma - metabolism; Malaria; Malaria - immunology; Malaria - metabolism; Male; Physiological aspects; Plasmodium falciparum; Plasmodium falciparum - immunology; Protozoan Proteins - immunology; Public health; Young Adult; Ghana
• ISSN: 1475-2875; 1475-2875
• DOI: 10.1186/s12936-016-1098-8

Malaria eradication requires a concerted approach involving all available control tools, and an effective vaccine would complement these efforts. An effective malaria vaccine should be able to induce protective immune responses in a genetically diverse population. Identification of immunodominant T cell epitopes will assist in determining if candidate vaccines will be immunogenic in malaria-endemic areas. This study therefore investigated whether class I-restricted T cell epitopes of two leading malaria vaccine antigens, Plasmodium falciparum circumsporozoite protein (CSP) and apical membrane antigen-1 (AMA1), could recall T cell interferon-γ responses from naturally exposed subjects using ex vivo ELISpot assays. Thirty-five subjects aged between 24 and 43 years were recruited from a malaria-endemic urban community of Ghana in 2011, and their peripheral blood mononuclear cells (PBMCs) were tested in ELISpot IFN-γ assays against overlapping 15mer peptide pools spanning the entire CSP and AMA1 antigens, and 9-10mer peptide epitope mixtures that included previously identified and/or predicted human leukocyte antigen (HLA) class 1-restricted epitopes from same two antigens. For CSP, 26 % of subjects responded to at least one of the nine 15mer peptide pools whilst 17 % responded to at least one of the five 9-10mer HLA-restricted epitope mixtures. For AMA1, 63 % of subjects responded to at least one of the 12 AMA1 15mer peptide pools and 51 % responded to at least one of the six 9-10mer HLA-restricted epitope mixtures. Following analysis of data from the two sets of peptide pools, along with bioinformatics predictions of class I-restricted epitopes and the HLA supertypes expressed by a subset of study subjects, peptide pools that may contain epitopes recognized by multiple HLA supertypes were identified. Collectively, these results suggest that natural transmission elicits ELISpot IFN-γ activities to class 1-restricted epitopes that are largely HLA-promiscuous. These results generally demonstrate that CSP and AMA1 peptides recalled ELISpot IFN-γ responses from naturally exposed individuals and that both CSP and AMA1 contain diverse class 1-restricted epitopes that are HLA-promiscuous and are widely recognized in this population.